The Evaluation of Serum Vitamin D Levels In Patients Having Chronic Plaque Psoriasis
Keywords:
Psoriasis, vitamin D deficiency, Vitamin D deficiency, Inadequate levelsAbstract
Background Psoriasis is chronic inflammatory disease having prevalence of 3 % in developed world. Most of these patients have low levels of serum vitamin D. Objective To determine vitamin D levels in serum of patients having chronic plaque psoriasis. Methods In this cross sectional study 400 patients who fulfilled the selection criteria were enrolled from Dermatology Department Mayo Hospital Lahore over 6 months (June 6, 2018 –December 6, 2018). Informed consent was taken. Demographic profile was noted. Their blood samples were taken after aseptic measures and sent to hospital laboratory for analysis of Vitamin D levels by ELISA method. The levels of Vitamin D3 were labeled as; Deficient (<20ng/ml), Insufficient (20ng /ml-30ng/ml), Desirable (>30ng/ml). Results The mean age of patients was 30.20 ± 5.81 years with range of 18-40 years. 177(44.2%) cases were 18-29 years old and 223(55.8%) cases were 30-40 years of age. There were 166(41.5%) males and 234(58.5%) cases were female. A total of 168(42%) cases had disease duration 6- >12 months and 232(58%) cases had disease duration > 12 months. A total of 118(29.5%) cases had mild, 183 (45.75%) cases had moderate and 99 (24.75%) cases had severe disease. There were 69(17.2%) cases that had desirable vitamin D levels, 135(33.8%) cases had vitamin D deficiency while 196 (49%) cases had insufficient vitamin D levels. Conclusion Findings of this study concludes that only 17.2% patients had desirable vitamin D levels while rest of the 82.8% cases had low levels of vitamin D levels. Hence, while treating patients with psoriasis, treatment of Vitamin D deficiency must also be considered.Keywords Psoriasis, Vitamin D, Vitamin D deficiency, inadequate levels.References
Talamonti M, D Adamio S, Bianchi L, Galluzzo M. The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature. Molecu Diagnos Therap. 2017:doi:10.1007/s40291-017-0274-z.
Ni C, Chiu MW. Psoriasis and comorbidities: links and risks. Clin Cosmet Investig Dermatol. 2014;7:119-32.
Mattozzi C, Paolino G, Richetta AG, Calvieri S. Psoriasis, vitamin D and the importance of the cutaneous barrier and integrity: An update. J Dermatol. 2016;43(5):507-14.
Soleymani T, Hung T, Soung J. The role of vitamin D in psoriasis: a review. Int J Dermatol. 2015;54(4):383-92.
Disphanurat W, Viarasilpa W, Chakkavittumrong P, Pongcharoen P.The Clinical Effect of Oral Vitamin D2 Supplementation on Psoriasis:A Double Blind, Randomized, Placebo Controlled Study. Dermatology Research and Practice,2019:1-9.
Michalek I, Loring B, John S. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205-12.
Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Ann Rev Immunol. 2014;32:227-55
Mostafa WZ, Hegazy RA. Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res. 2015;6(6):793-804.
Pavlov SI, Ivanova II, Gerova D. Vitamin D status in patients with psoriasis. Script Scientific Medic. 2016;48(1):50-4.
Zuchi MF, Azevedo PdO, Tanaka AA, Schmitt JV, Martins LEAM. Serum levels of 25-hydroxy vitamin D in psoriatic patients. Ana Bras Dermatol. 2015;90(3):
Bhat GH, Guldin S, Khan MS, et al.Vitamin D Status in Psoriasis: impact and clinical correlation.BMC Nutrition.2022;8:115.
Gupta S, Garg P, Gupta N. Serum 25-hydroxyvitamin D level in psoriasis patients: a case control study. Inter J Research Dermatol.2019; 5:01.430-2.